These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8788207)
1. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets. Ohno M; Kishimoto T; Tada M Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207 [TBL] [Abstract][Full Text] [Related]
2. Assessment of production of endothelium-derived relaxing factor (EDRF) by cultured human vascular endothelial cells based on its anti-aggregatory effect on human platelets. Ohno M; Kishimoto T; Jidoi J; Tada M Hum Cell; 1994 Mar; 7(1):68-71. PubMed ID: 8025024 [TBL] [Abstract][Full Text] [Related]
3. Effect of methylmercury (CH3HgCl) injury on nitric oxide synthase (NOS) activity in cultured human umbilical vascular endothelial cells. Kishimoto T; Oguri T; Tada M Toxicology; 1995 Nov; 103(1):1-7. PubMed ID: 8525486 [TBL] [Abstract][Full Text] [Related]
4. Assessment of production of endothelium-derived relaxing factor by cultured porcine cerebral microvessel endothelial cells. Kishimoto T; Oguri T; Matsumura K; Kawamoto K; Tada M Hum Cell; 1995 Mar; 8(1):19-24. PubMed ID: 7669748 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. Broekman MJ; Eiroa AM; Marcus AJ Blood; 1991 Aug; 78(4):1033-40. PubMed ID: 1868238 [TBL] [Abstract][Full Text] [Related]
6. Effect of cadmium (CdCl2) on cell proliferation and production of EDRF (endothelium-derived relaxing factor) by cultured human umbilical arterial endothelial cells. Kishimoto T; Oguri T; Ohno M; Matsubara K; Yamamoto K; Tada M Arch Toxicol; 1994; 68(9):555-9. PubMed ID: 7998821 [TBL] [Abstract][Full Text] [Related]
7. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Alheid U; Frölich JC; Förstermann U Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684 [TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Durante W; Kroll MH; Vanhoutte PM; Schafer AI Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423 [TBL] [Abstract][Full Text] [Related]
9. Assessment of endothelium-derived relaxing factor from human coronary arteries using the anti-platelet aggregatory effect. Kishimoto T; Fukuzawa Y; Abe M; Hashimoto M; Tada M Nihon Eiseigaku Zasshi; 1992 Feb; 46(6):1043-50. PubMed ID: 1556827 [TBL] [Abstract][Full Text] [Related]
10. Copper enhances EDNO (endothelium-derived nitric oxide) activity by cultured human vascular endothelial cells. Kishimoto T; Oguri T; Ueda D; Tada M Hum Cell; 1996 Jun; 9(2):117-24. PubMed ID: 9183639 [TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries. Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689 [TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Macdonald PS; Read MA; Dusting GJ Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674 [TBL] [Abstract][Full Text] [Related]
13. Alkaline buffers release EDRF from bovine cultured aortic endothelial cells. Mitchell JA; de Nucci G; Warner TD; Vane JR Br J Pharmacol; 1991 Jun; 103(2):1295-302. PubMed ID: 1884092 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies. Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618 [TBL] [Abstract][Full Text] [Related]
16. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell. Johns RA; Peach MJ; Linden J; Tichotsky A Circ Res; 1990 Oct; 67(4):979-85. PubMed ID: 2170053 [TBL] [Abstract][Full Text] [Related]
17. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599 [TBL] [Abstract][Full Text] [Related]
18. Agents that modify EDRF formation alter antiplatelet properties of brain arteriolar endothelium in vivo. Nishimura H; Rosenblum WI; Nelson GH; Boynton S Am J Physiol; 1991 Jul; 261(1 Pt 2):H15-21. PubMed ID: 1858916 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor. Stork AP; Cocks TM Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260 [TBL] [Abstract][Full Text] [Related]
20. Studies on the importance of the proposed release of nitric oxide from platelets. Mollace V; Salvemini D; Vane J Thromb Res; 1991 Dec; 64(5):533-42. PubMed ID: 1725563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]